Insurance price determination standards for new drugs under review.

Published: 1999-08-26 13:43:00

Updated: 1999-08-26 13:43:00

The MOHW plans to make a Task Force for overall review of the new standards for insurance drug price determination that should be more reasonable and objective in consideration with characteristics of drugs and their unique features. The task force will improve the price determination for the dru...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK